Huapont Life Sciences Co Ltd (002004) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Huapont Life Sciences Co Ltd (002004) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥635.17 Million ≈ $92.95 Million USD) by net assets (CN¥16.10 Billion ≈ $2.36 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Huapont Life Sciences Co Ltd - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Huapont Life Sciences Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Huapont Life Sciences Co Ltd for a breakdown of total debt and financial obligations.
Huapont Life Sciences Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Huapont Life Sciences Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
ERAMET EO 305 ADR 1/10
F:ER70
|
N/A |
|
Dole PLC
NYSE:DOLE
|
0.064x |
|
Eurocommercial Properties N.V.
AS:ECMPA
|
0.020x |
|
Jiangsu Zijin Rural Commercial Bank Co Ltd
SHG:601860
|
0.019x |
|
Xinyu Iron & Steel Co Ltd
SHG:600782
|
0.050x |
|
FAP Agri Tbk PT
JK:FAPA
|
0.182x |
|
Amore Group
KO:002790
|
-0.003x |
|
Res Robex Inc
V:RBX
|
0.073x |
Annual Cash Flow Conversion Efficiency for Huapont Life Sciences Co Ltd (2002–2024)
The table below shows the annual cash flow conversion efficiency of Huapont Life Sciences Co Ltd from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Huapont Life Sciences Co Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥15.47 Billion ≈ $2.26 Billion |
CN¥1.63 Billion ≈ $237.83 Million |
0.105x | +9.60% |
| 2023-12-31 | CN¥16.58 Billion ≈ $2.43 Billion |
CN¥1.59 Billion ≈ $232.59 Million |
0.096x | -34.12% |
| 2022-12-31 | CN¥16.55 Billion ≈ $2.42 Billion |
CN¥2.41 Billion ≈ $352.34 Million |
0.145x | +81.32% |
| 2021-12-31 | CN¥15.82 Billion ≈ $2.32 Billion |
CN¥1.27 Billion ≈ $185.79 Million |
0.080x | -52.20% |
| 2020-12-31 | CN¥14.14 Billion ≈ $2.07 Billion |
CN¥2.37 Billion ≈ $347.20 Million |
0.168x | +6.76% |
| 2019-12-31 | CN¥13.24 Billion ≈ $1.94 Billion |
CN¥2.08 Billion ≈ $304.68 Million |
0.157x | +5.02% |
| 2018-12-31 | CN¥12.75 Billion ≈ $1.87 Billion |
CN¥1.91 Billion ≈ $279.29 Million |
0.150x | +236.59% |
| 2017-12-31 | CN¥13.30 Billion ≈ $1.95 Billion |
CN¥591.40 Million ≈ $86.54 Million |
0.044x | -6.99% |
| 2016-12-31 | CN¥10.70 Billion ≈ $1.57 Billion |
CN¥511.90 Million ≈ $74.91 Million |
0.048x | +45.38% |
| 2015-12-31 | CN¥10.41 Billion ≈ $1.52 Billion |
CN¥342.45 Million ≈ $50.11 Million |
0.033x | -58.65% |
| 2014-12-31 | CN¥5.73 Billion ≈ $838.76 Million |
CN¥455.96 Million ≈ $66.72 Million |
0.080x | -8.68% |
| 2013-12-31 | CN¥4.01 Billion ≈ $587.13 Million |
CN¥349.51 Million ≈ $51.14 Million |
0.087x | -0.07% |
| 2012-12-31 | CN¥2.96 Billion ≈ $432.69 Million |
CN¥257.75 Million ≈ $37.72 Million |
0.087x | +66.69% |
| 2011-12-31 | CN¥2.59 Billion ≈ $378.40 Million |
CN¥135.23 Million ≈ $19.79 Million |
0.052x | -32.16% |
| 2010-12-31 | CN¥1.04 Billion ≈ $151.57 Million |
CN¥79.84 Million ≈ $11.68 Million |
0.077x | -44.01% |
| 2009-12-31 | CN¥897.32 Million ≈ $131.31 Million |
CN¥123.53 Million ≈ $18.08 Million |
0.138x | -1.49% |
| 2008-12-31 | CN¥814.07 Million ≈ $119.12 Million |
CN¥113.76 Million ≈ $16.65 Million |
0.140x | +28.94% |
| 2007-12-31 | CN¥730.86 Million ≈ $106.95 Million |
CN¥79.21 Million ≈ $11.59 Million |
0.108x | -14.27% |
| 2006-12-31 | CN¥522.90 Million ≈ $76.52 Million |
CN¥66.10 Million ≈ $9.67 Million |
0.126x | +27.50% |
| 2005-12-31 | CN¥440.68 Million ≈ $64.49 Million |
CN¥43.69 Million ≈ $6.39 Million |
0.099x | -43.60% |
| 2004-12-31 | CN¥401.64 Million ≈ $58.77 Million |
CN¥70.60 Million ≈ $10.33 Million |
0.176x | -54.80% |
| 2003-12-31 | CN¥145.74 Million ≈ $21.33 Million |
CN¥56.68 Million ≈ $8.29 Million |
0.389x | +7.74% |
| 2002-12-31 | CN¥102.18 Million ≈ $14.95 Million |
CN¥36.88 Million ≈ $5.40 Million |
0.361x | -- |
About Huapont Life Sciences Co Ltd
Huapont Life Sciences Co.,Ltd. engages in the medicine, medical care, agrochemicals, new materials, tourism, and other businesses in China and internationally. The company is involved in the production and sale of pharmaceutical preparations and raw materials. It also offers medicines for skin, tuberculosis, anti-infection, respiratory, anti-tumor, and cardiovascular, as well as health management… Read more